Rouprêt Morgan, Hupertan Vincent, Comperat Eva, Drouin Sarah J, Phé Véronique, Xylinas Evanguelos, Demanse David, Sibony Mathilde, Richard Francois, Cussenot Olivier
Department of Urology, Groupe Hospitalo-Universitaire EST, Pitié-Salpétriére, Paris, France.
BJU Int. 2009 Sep;104(6):813-7; discussion 817-8. doi: 10.1111/j.1464-410X.2009.08473.x. Epub 2009 Feb 27.
To establish the predictive accuracy of the Kattan preoperative nomogram by comparing predictions at 5 years with actual progression in patients who had a radical prostatectomy (RP).
We reviewed the data for 928 patients treated by RP as a first-line treatment for localized prostate cancer, between 1994 and 2005. Recurrence was defined as one prostate-specific antigen (PSA) level of >0.4 ng/mL. The 5-year progression-free probability (PFP) rate was evaluated on censured data using the Kaplan-Meier method. Relationships between all predictor variables included in the Kattan nomogram (PSA level, biopsy Gleason scores and clinical stage) and survival were evaluated by Cox proportional-hazards regression analysis. The discriminating ability of the nomogram was assessed by the concordance index (c-index). Bootstrapping was used to assess confidence intervals (CIs), and then the calibration was assessed.
The median follow-up was 60 months. Overall, 177 (19%) patients had a recurrence; the 5-year PFP rate (95% CI) was 80.9 (78-83)%. Of the three variables included in the nomogram, all were associated with recurrence in a multivariate analysis (P < 0.001). The c-index (95% CI) was only 0.664 (0.584-0.744). In general, the nomogram was not well calibrated.
There was a discrepancy between the predicted PFP as estimated by the Kattan nomogram and actual relapse in this group of patients. Clinicians should be aware that the nomogram is less accurate when used outside the population used to formulate the nomogram. Although more accurate tools are needed, the Kattan nomogram is still the best choice for urologists so far.
通过比较接受根治性前列腺切除术(RP)患者5年的预测结果与实际进展情况,确定Kattan术前列线图的预测准确性。
我们回顾了1994年至2005年间928例接受RP作为局限性前列腺癌一线治疗患者的数据。复发定义为前列腺特异性抗原(PSA)水平>0.4 ng/mL。使用Kaplan-Meier方法对删失数据评估5年无进展概率(PFP)率。通过Cox比例风险回归分析评估Kattan列线图中所有预测变量(PSA水平、活检Gleason评分和临床分期)与生存率之间的关系。通过一致性指数(c指数)评估列线图的鉴别能力。使用自举法评估置信区间(CI),然后评估校准情况。
中位随访时间为60个月。总体而言,177例(19%)患者出现复发;5年PFP率(95%CI)为80.9(78-83)%。列线图中的三个变量在多变量分析中均与复发相关(P<0.001)。c指数(95%CI)仅为0.664(0.584-0.744)。总体而言,列线图校准不佳。
在这组患者中,Kattan列线图估计的预测PFP与实际复发之间存在差异。临床医生应意识到,当在用于制定列线图的人群之外使用时,列线图的准确性较低。尽管需要更准确的工具,但Kattan列线图仍是目前泌尿外科医生的最佳选择。